Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers

Frontiers in Neuroscience

Volumn , Issue 7 MAY, 2013, Pages

  Advokat, Claire ^a   Scheithauer, Mindy ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Amphetamine; Attention deficit hyperactivity disorder; Cognitive enhancement; Episodic memory; Methylphenidate; Stimulants

Indexed keywords

LEVODOPA;

ACADEMIC ACHIEVEMENT; ATTENTION DEFICIT DISORDER; COGNITION; EMOTION; ENVIRONMENTAL FACTOR; EPISODIC MEMORY; FRUSTRATION; FUNCTIONAL STATUS; HEADACHE; HEART RATE; HIGH RISK BEHAVIOR; HUMAN; IRRITABILITY; MOOD; MOTIVATION; NAUSEA; NEUROPSYCHOLOGICAL TEST; QUALITY OF LIFE; REVIEW; UNDERGRADUATE STUDENT; WAKEFULNESS;

EID: 84878994831     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2013.00082     Document Type: Review

References (64)

1. Advokat, C. (2009). What exactly are the benefits of stimulants for ADHD? J. Atten. Dis. 12, 495-498. doi: 10.1177/1087054708329781
2. Advokat, C. (2010). What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci. Biobehav. Rev. 34, 1256-1266. doi: 10.1016/j.neubiorev.2010.03.006
3. Advokat, C., Lane, S., and Luo, C. (2011). College students with and without ADHD: comparison of self-report of medication usage, study habits and academic achievement. J. Atten. Dis. 15, 656-666. doi: 10.1177/1087054710371168
4. Advokat, C., Martino, L., and Guidry, D. (2008). Licit and illicit use of attention-deficit hyperactivity (ADHD) medication by college students. J. Am. Coll. Health 56, 601-606. doi: 10.3200/JACH.56.6.601-606
5. Advokat, C., and Vinci, C. (2012). "Do stimulant medications for attention deficit/hyperactivity disorder (ADHD) enhance cognition?" in Current Directions in ADHD and Its Treatment, ed J. M. Norvilitis (Rijeka: InTech), 125-156.
6. Agay, N., Yechiam, E., Carmel, Z., and Levkovitz, Y. (2010). Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology 210, 511-519. doi: 10.1007/s00213-010-1853-4
7. Arria, A. M., Caldeira, K. M., O'Grady, K. E., Vincent, K. B., Johnson, E. P., and Wish, E. D. (2008). Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy 28, 156-169. doi: 10.1592/phco.28.2.156
8. Arria, A. M., and DuPont, R. L. (2010). Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do. J. Addict. Dis. 29, 417-426. doi: 10.1080/10550887.2010.509273
9. Barrilleaux, K., and Advokat, C. (2009). Attribution and self-evaluation of CPT task performance in medicated and unmedicated adults with attention-deficit/hyperactivity disorder. J. Atten. Dis. 12, 291-298. doi: 10.1177/1087054708314604
10. Baumeister, A. A., Henderson, K., Pow, J. L., and Advokat, C. (2012). The early history of the neuroscience of attention-deficit/hyperactivity disorder. J. Hist. Neurosci. 21, 263-279. doi: 10.1080/0964704X.2011.595649
11. Bidwell, L. C., McClernon, F. J., and Kollins, S. H. (2011). Cognitive enhancers for the treatment of ADHD. Pharmacol. Biochem. Behav. 99, 262-274. doi: 10.1016/j.pbb.2011.05.002
12. Biederman, J., Fried, R., Hammerness, P., Surman, C., Mehler, B., Petty, C. R., et al. (2012). The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. J. Psychiat. Res. 46, 484-491. doi: 10.1016/j.jpsychires.2012.01.007
13. Biederman, J., Mick, E., Fried, R., Wilner, N., Spencer, T. J., and Faraone, S. V. (2011). Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. Eur. Neuropsychopharmacol. 21, 508-515. doi: 10.1016/j.euroneuro.2010.11.005
14. Brignell, C. M., Rosenthal, J., and Curran, H. V. (2007). Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam. J. Psychopharmacol. 21, 673-683. doi: 10.1177/0269881107077351
15. Buitelaar, J. K., Casas, M., Philipsen, A., Kooij, J. J. S., Ramos-Quiroga, J. A., Dejonckheere, J., et al. (2012a). Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate. Psychol. Med. 42, 195-204. doi: 10.1017/S0033291711000845
16. Buitelaar, J. K., Trott, G.-E., Hofecker, M., Waechter, S., Berwaertes, J., Dejonkheere, J., et al. (2012b). Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD. Int. J. Neuropsychopharmacol. 15, 1-13. doi: 10.1017/S1461145711001131
17. Cahill, L., and McGaugh, J. L. (1995). A novel demonstration of enhanced memory associated with emotional arousal. Conscious. Cogn. 4, 410-421. doi: 10.1006/ccog.1995.1048
18. Caisley, H., and Müller, U. (2012). Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review. Eur. Psychiatry 27, 343-349. doi: 10.1016/j.eurpsy.2012.01.002
19. Campbell-Meiklejohn, D., Simonsen, A., Scheel-Krüger, J., Wohlert, V., Gjerløff, T., Frith, C. D., et al. (2012a). In for a penny, in for a pound: methylphenidate reduces the inhibitory effect of high stakes on persistent risky choice. J. Neurosci. 32, 13032-13038. doi: 10.1523/JNEUROSCI.0151-12.2012
20. Campbell-Meiklejohn, D., Simonsen, A., Jensen, M., Wohlert, V., Gjerløff, T., Scheel-Krüger, J., et al. (2012b). Modulation of social influence by methylphenidate. Neuropsychopharmacology 37, 1517-1525. doi: 10.1038/npp.2011.337
21. Castells, X., Cunill, R., and Capellà, D. (2013). Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials. Eur. J. Clin. Pharmacol. 69, 347-356. doi: 10.1007/s00228-012-1390-7
22. Chowdhury, R., Guitart-Masip, M., Bunzeck, N., Dolan, R. J., and Düzel, E. (2012). Dopamine modulates episodic memory persistence in old age. J. Neurosci. 32, 14193-14204. doi: 10.1523/JNEUROSCI.1278-12.2012
23. Cox, D. J., Davis, M., Mikami, A. Y., Singh, H., Merkel, R. L., and Burket, R. (2012). Long-acting methylphenidate reduces collision rates of young adult drivers with attention deficit/hyperactivity disorder. J. Clin. Psychopharmacol. 32, 225-230. doi: 10.1097/JCP.0b013e3182496dc5
24. de Jongh, R., Bolt, I., Schermer, M., and Olivier, B. (2008). Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci. Biobehav. Rev. 32, 760-776. doi: 10.1016/j.neubiorev.2007.12.001
25. de Wit, H., Enggasser, J. L., and Richards, J. B. (2002). Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27, 813-825. doi: 10.1016/S0893-133X(02)00343-3
26. Farah, M. J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., et al. (2004). Neurocognitive enhancement: what can we do and what should we do? Nature Rev. Neurosci. 5, 421-425. doi: 10.1038/nrn1390
27. Forlini, C., Gauthier, S., and Racine, E. (2012). Should physicians prescribe cognitive enhancers to healthy people? CMAJ. doi: 10.1503/cmaj.121508
28. Getahun, D., Jacobsen, S. J., Fassett, M. J., Chen, W., Demissie, K., and Rhoads, G. G. (2013). Recent trends in childhood attention deficit/hyperactivity disorder. JAMA Pediatr. 167, 282-288. doi: 10.1001/2013.jamapediatrics.401
29. Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., et al. (2008). Towards responsible use of cognitive enhancing drugs by the healthy. Nature 456, 702-705. doi: 10.1038/456702a
30. Harris, J. (2009). Is it acceptable for people to take methylphenidate to enhance performance? Yes. BMJ 338:b1955. doi: 10.1136/bmj.b1955
31. Hester, R., Nandam, L. S., O'Connell, R. G., Wagner, J., Strudwick, M., Nathan, P. J., et al. (2012). Neurochemical enhancement of conscious error awareness. J. Neurosci. 32, 2619-2627. doi: 10.1523/JNEUROSCI.4052-11.2012
32. Ilieva, I., Boland, J., and Farah, M. J. (2013). Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology 64, 496-505. doi: 10.1016/j.neuropharm.2012.07.021
33. Izquierdo, I., Bevilaqua, L. R., Rossato, J. I., Lima, R. H., Medina, J. H., and Cammarota, M. (2008). Age-dependent and age-independent human memory persistence is enhanced by delayed posttraining methylphenidate administration. Proc. Natl. Acad. Sci. U.S.A. 105, 19504-19507. doi: 10.1073/pnas.0810650105
34. Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., et al. (2006). The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am. J. Psychiatry 163, 716-723. doi: 10.1176/appi.ajp.163.4.716
35. Langberg, J. M., and Becker, S. P. (2012). Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder? Clin. Child Fam. Psychol. Rev. 15, 215-233. doi: 10.1007/s10567-012-0117-8
36. Larriviere, D., Williams, M. A., Rizzo, M., and Bonnie, R. J. (2009). Responding to requests from adult patients for neuroenhancements. Guidance of the ethics, law and humanities committee. Neurology 73, 1406-1412. doi: 10.1212/WNL.0b013e3181beecfe
37. Lensing, M. B., Zeiner, P., Sandvik, L., and Opjordsmoen, S. (2013). Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey. J. Clin. Psychiatry 74, e87-e93. doi: 10.4088/JCP.12m07714
38. Lucke, J. C., Bell, S., Partridge, B., and Hall, W. D. (2011). Deflating the neuroenhancement bubble. AJOB Neurosci. 2, 38-43. doi: 10.1080/21507740.2011.611122
39. Maul, J., and Advokat, C. (2013). Stimulant medications for attention-deficit/hyperactivity disorder (ADHD) improve memory of emotional stimuli in ADHD-diagnosed college students. Pharmacol. Biochem. Behav. 105, 58-62. doi: 10.1016/j.pbb.2013.01.021
40. McCloskey, M., Palmer, A. A., and de Wit, H. (2010). Are attention lapses related to d-amphetamine liking? Psychopharmacology 208, 201-209. doi: 10.1007/s00213-009-1719-9
41. O'Connell, R. G., Bellgrove, M. A., Dockree, P. M., Lau, A., Hester, R., Garavan, H., et al. (2009). The neural correlates of deficient error awareness in attention-deficit hyperactivity disorder (ADHD). Neuropsychologia 47, 1149-1159. doi: 10.1016/j.neuropsychologia.2009.01.01
42. Olfson, M., Blanco, C., Wang, S., and Greenhill, L. L. (2013). Trends in office-based treatment of adults with stimulants in the United States. J. Clin. Psychiatry 74, 43-50. doi: 10.4088/JCP.12m07975
43. Oliver, M. L., Nigg, J. T., Cassavaugh, N. D., and Backs, R. W. (2012). Behavioral and cardiovascular responses to frustration during simulated driving tasks in young adults with and without attention disorder symptoms. J. Atten. Dis. 16, 478-490. doi: 10.1177/1087054710397132
44. Outram, S. M. (2010). The use of methylphenidate among students: the future of enhancement? J. Med. Ethics 36, 198-202. doi: 10.1136/jme.2009.034421
45. Prehn-Kristensen, A., Krauel, K., Hinrichs, H., Fischer, J., Malecki, U., Schuetze, H., et al. (2011). Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder. Brain Res. 1388, 56-68. doi: 10.1016/j.brainres.2011.02.075
46. Quednow, B. B. (2010). Ethics of neuroenhancement: a phantom debate. Biosocieties 5, 153-156. doi: 10.1057/biosoc.2009.13
47. Ragan, C. I., Bard, I., and Singh, I. (2013). What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology 64, 588-595. doi: 10.1016/j.neuropharm.2012.06.016
48. Rasmussen, N. (2008). America's first amphetamine epidemic 1929-1971. Am. J. Pub. Health 98, 974-985. doi: 10.2105/AJPH.2007.110593
49. Repantis, D., Schlattmann, P., Laisney, O., and Heuser, I. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol. Res. 62, 187-206. doi: 10.1016/j.phrs.2010.04.002
50. Retz, W., Stieglitz, R.-D., Corbisiero, S., Retz-Junginger, P., and Rösler, M. (2012). Emotional dysregulation in adult ADHD: what is the empirical evidence? Expert Rev. Neurother. 12, 1241-1251. doi: 10.1586/ern.12.109
51. Robbins, T. W., and Sahakian, B. J. (1979). "Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioral pharmacology. Neuropharmacology 18, 931-950. doi: 10.1016/0028-3908(79)90157-6
52. Schwarz, A. (2012 June 9). Risky rise of the good-grade pill; Seeking Academic Edge, Teenagers Abuse Stimulants. New York Times.
53. Schwarz, A. (2013 February 2). Drowned in a stream of prescriptions. New York Times.
54. Smith, M. E., and Farah, M. J. (2011). Are prescription stimulants "Smart Pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol. Bull. 137, 717-741. doi: 10.1037/a0023825
55. St. Onge, J. R., Chiu, Y. C., and Floresco, S. B. (2010). Differential effects of dopaminergic manipulations on risky choice. Psychopharmacology 211, 209-221. doi: 10.1007/s00213-010-1883-y
56. Stix, G. (2009). Turbocharging the brain. Sci. Am. 301, 46-55. doi: 10.1038/scientificamerican1009-46
57. Swanson, J., Baler, R. D., and Volkow, N. D. (2011). Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology 36, 207-226. doi: 10.1038/npp.2010.160
58. Szalavitz, M. (2012). Teens Taking ADHD Drugs to Get Good Grades: How Big a Problem is It? Available online at: http://healthland.time.com/2012/06/11/kids-taking-adhd-drugs-to-get-good-grades-how-big-a-problem-is-it/#ixzz2K9ZxWqLV
59. Talbot, M. (2009). Brain gain: the underground world of neuroenhancing drugs. New Yorker 32-43.
60. Toomey, S. L., Sox, C. M., Rusinak, D., and Finkelstein, J. A. (2012). Why do children with ADHD discontinue their medication? Clin. Pediatr. 51, 763-769. doi: 10.1177/0009922812446744
61. Varga, M. D. (2012). Adderall abuse on college campuses: a comprehensive literature review. J. Evid. Based Soc. Work 9, 293-313. doi: 10.1080/15433714.2010.525402
62. Wardle, M. C., Treadway, M. T., Mayo, L. M., Zald, D. H., and de Wit, H. (2011). Amping up effort: effects of d-amphetamine on human effort-based decision-making. J. Neurosci. 31, 16597-16602. doi: 10.1523/JNEUROSCI.4387-11.2011
63. Wilens, T. E., Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., et al. (2008). Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J. Am. Acad. Child Psy. 47, 21-31. doi: 10.1097/chi.0b013e31815a56f1
64. Willcutt, E. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9, 490-499. doi: 10.1007/s13311-012-0135-8